v

venBio Partners

6 employees

VenBio is a life sciences investment firm that partners with industry leaders to build medicines and technologies.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology57
Health Care41
Pharmaceutical29
Therapeutics28
Biopharma16
Life Science16
Medical15
Medical Device11
Immuno-Oncology5
Gene Therapy4
Drug Development4
Research and Development3
Novel Biologics3
CD473
Innovation3
Health Diagnostics3
Nephrology3
Cell Therapy3
Drug Discovery3
Medicinal Chemistry3

Funding rounds participated in

$60M sweet spot round size

Most of their 65 investments are in rounds between $36M and $80M

Basic info

Sectors

Financial Services
Business Development
Life Science
Venture Capital

Date founded

2009

Investments made

P

Pharvaris raised $70M on June 20, 2023

Investors: General Atlantic, Foresite Capital and venBio Partners

U

Undisclosed raised $60M on June 20, 2023

Investors: Illumina Ventures and venBio Partners

E

Entact Bio raised $81M on December 6, 2022

Investors: Qiming Venture Partners USA, Logos Global Management, LP, Surveyor Capital, Brandon Capital Partners, Abingworth and venBio Partners

F

FogPharma raised $178M on November 21, 2022

Investors: T. Rowe Price, GV, The Invus Group, Farallon Capital Management and venBio Partners

I

IMMPACT BIO USA INC raised $111M on January 20, 2022

Investors: RM Global Healthcare Investment Banking & Life Sciences Advisory, Decheng Capital, OrbiMed Advisors, Surveyor Capital, Foresite Capital and venBio Partners

C

Ceptur Therapeutics raised $75M on January 19, 2022

Investors: Perceptive Advisors, Qiming Venture Partners, LifeSci Venture Partners, Bristol-Myers Squibb, UK, Affinity Asset Advisors and venBio Partners

N

North Sea group raised $80M on December 17, 2021

Investors: Ysios Capital, -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, Sofinnova Ventures, Russia technology fund and venBio Partners

H

HistoWiz raised $32M on October 19, 2021

Investors: Vivo Capital and venBio Partners

C

CinCor Pharma, Inc. raised $143M on October 12, 2021

Investors: Sixty Degree Capital, Sofinnova Ventures, Russia technology fund, Lilly Asia Ventures, Sofinnova Partners, General Atlantic, Perceptive Advisors, RTW Investments, LP, Omega Funds and venBio Partners

V

Ventyx Biosciences raised $51M on September 20, 2021

Investors: Third Point LLC, Qiming Venture Partners USA, Surveyor Capital, Vivo Capital, RTW Investments, LP, OrbiMed Advisors, Logos Global Management, LP, Wellington Management and venBio Partners

FAQ